Non-invasive urothelial neoplasms: according to the most recent WHO classification.
about
Identification of common differentially expressed genes in urinary bladder cancerIntravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancerPrognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patientsSpotlight on differentially expressed genes in urinary bladder cancer.The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancerComparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer.Role of morphometry and proliferative parameters in grading of urothelial neoplasms.Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.The pathology of bladder cancer: An update on selected issues.The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopyBladder cancer: clinical and pathological profile.The current classification of urothelial neoplasms.Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals.Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer.Surgical management of bladder transitional cell carcinoma in a vesicular diverticulum: case report.Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.Cost of illness of urothelial bladder cancer in ItalyIntravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: a New Zealand perspective.Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study.MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.Expression of heat shock proteins in premalignant and malignant urothelial lesions of bovine urinary bladder.Implication of RAF and RKIP genes in urinary bladder cancer.[Non-invasive and invasive urothelial tumours: special challenges in uropathological diagnostics].[Photodynamic therapy of bladder cancer. A new option].Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients.Illumination of a Vision-How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research.Expression and clinical significance of androgen receptor in bladder cancer: A meta-analysis.Angiomyxoid tumor with an intermediate feature between cellular angiofibroma and angiomyofibroblastoma in the male inguinal region.Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP).FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients.
P2860
Q21135503-2CFF1DE1-E9F3-4C5E-8348-0D097374D824Q24186083-10C16433-1FA5-4623-A6A6-8F939A596C90Q33684090-FB9206F5-05DD-443B-926C-E4D24F7AF435Q33869194-6219C1CC-5AF3-4FBC-A094-989F9B913AE8Q34452006-A73A3154-0115-4B69-AD7C-27440D6F5BF4Q34769031-9F76E914-D130-4569-8686-2CCC1E99C54BQ35533827-D7612731-8821-4C6A-B7D9-8118F2C66CAEQ35769446-A995375C-19CE-4EC5-B3C7-4783931BA6AEQ36552067-EC4F05BF-FBBA-454E-946F-BEBF52E279F5Q36786491-7C49FD7B-A390-4AED-B8F8-4735C791533FQ37278983-59C9DF61-1224-4641-BAAA-5D2173636F24Q37507537-172AD29B-E826-4F65-B788-5D66BB3FB415Q37570005-4FDF0782-8C32-4437-8D08-299DE0BCF151Q37660290-3C0BB191-18B8-4D3A-82F1-E442D5AF1DB8Q37743536-ED313DBA-6A00-4A40-A1D9-BC5FE1099835Q37909543-D37BA4C0-6FD1-4CCF-B57F-AB44FBCE2F57Q38272240-AED41194-2277-4EBF-80C0-61F28A8A9B25Q38645796-291DC66B-3759-4E40-86B6-030E2B1079D4Q38924479-EDBE734E-8F4D-4580-8E77-33CF8ABDC4E0Q40734375-30BEEFCB-9C02-4F38-A136-FFBE88B6735FQ40893287-80301B45-13E0-4FB1-A30B-0AC0F45019DFQ40971526-6168BB44-D6C1-4F93-84E8-918AD6397CDBQ41864486-5AAA78F8-DDF7-4664-AC82-6AC7480C4C13Q43890261-1E18D781-C0DC-441A-8C7E-52B358CAD40EQ44652749-FF8BF08F-7DC6-428F-A09F-DF48C76AC570Q44727503-4CCC67CD-75F0-4BD4-974A-90D7621424D9Q47098363-F23E333A-7B7B-4132-A4A2-2CDC323D7C28Q47109071-DFA81AE8-6FDE-4652-B20A-0D3A54E6C5ADQ47110297-6BECCA5A-FDDF-47DE-B267-A159759913DFQ47144988-91EEF278-8F98-40FC-BCC9-244D5E5772BBQ51839956-BEC14D77-9D9B-4E62-A3EB-C3B9E6A8BBF3Q53158342-B87BB64D-1829-4AEF-B64E-FBF336CC736CQ54215764-622697C3-1755-40DF-ACE7-80E8B1CF229CQ55173600-D46595A6-E5D4-410A-B93D-F72C822BE280
P2860
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
@ast
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
@en
type
label
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
@ast
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
@en
prefLabel
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
@ast
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
@en
P1433
P1476
Non-invasive urothelial neoplasms: according to the most recent WHO classification.
@en
P2093
Antonio Lopez-Beltran
P304
P356
10.1016/J.EURURO.2004.03.017
P407
P577
2004-08-01T00:00:00Z